Literature DB >> 32651115

Dynamics of G2P[4] strain evolution and rotavirus vaccination: A review of evidence for Rotarix.

Gyneth Lourdes Bibera1, Jing Chen2, Priya Pereira3, Bernd Benninghoff4.   

Abstract

Rotavirus (RV) gastroenteritis is a vaccine-preventable disease that creates high medical and economic burden in both developed and developing countries. Worldwide, more than 100 countries have introduced RV vaccines in their national immunization programs, and the remarkable impact of reducing the burden of severe childhood gastroenteritis has been unequivocally demonstrated. Currently, 2 oral vaccines (Rotarix, GSK and RotaTeq, Merck) are widely utilized. Recent temporary increases in the relative prevalence of G2P[4] RV strains have been observed in countries implementing RV vaccination. This comprehensive literature review aims to provide an insight on RV genotype evolution in the context of mass vaccination with Rotarix, particularly in the case of G2P[4]. In the post-vaccine era, strain surveillance data indicated temporal and spatial changes in countries both with and without RV vaccination programs. Annual fluctuations in G2P[4] prevalence seem to occur naturally, with no substantial differences between countries using Rotarix, RotaTeq or mixed vaccination programs. Moreover, Rotarix has been shown to be efficacious and effective against gastroenteritis caused by non-vaccine strains, including G2P[4]. These data indicate that shifts in RV genotype distribution are likely to constitute an inherent process of virus evolution to infect the human gut. Following RV vaccine introduction, incidences of RV gastroenteritis declined dramatically and mass vaccination will likely maintain this status, despite possible fluctuations in the relative distribution of genotypes. There is no conclusive evidence of unusual burst of new or vaccine-escape strains since global RV vaccines use. The emergence of strains with a potential to increase the current burden of RV disease should be continuously monitored and can only be established by exhaustive characterization of strains, including whole genomic sequencing. Given the natural fluctuations in RV strains over time, caution is advised when interpreting temporal changes in RV strain dynamics, as they could mistakenly be attributed to vaccination.
Copyright © 2020 GlaxoSmithKline Biologicals S.A. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  G2P[4]; Rotarix; genotypes; rotavirus; surveillance

Mesh:

Substances:

Year:  2020        PMID: 32651115     DOI: 10.1016/j.vaccine.2020.06.059

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Do Rotavirus Strains Affect Vaccine Effectiveness? A Systematic Review and Meta-analysis.

Authors:  Jordan E Cates; Avnika B Amin; Jacqueline E Tate; Ben Lopman; Umesh Parashar
Journal:  Pediatr Infect Dis J       Date:  2021-12-01       Impact factor: 2.129

2.  The Long-Term Impact of Rotavirus Vaccines in Korea, 2008-2020; Emergence of G8P[8] Strain.

Authors:  Kwang Gon Kim; Hye-Young Kee; Hye Jung Park; Jae Keun Chung; Tae Sun Kim; Min Ji Kim
Journal:  Vaccines (Basel)       Date:  2021-04-20

3.  High prevalence of circulating DS-1-like human rotavirus A and genotype diversity in children with acute gastroenteritis in Thailand from 2016 to 2019.

Authors:  Siripat Pasittungkul; Fajar Budi Lestari; Jiratchaya Puenpa; Watchaporn Chuchaona; Nawarat Posuwan; Jira Chansaenroj; John Mauleekoonphairoj; Natthinee Sudhinaraset; Nasamon Wanlapakorn; Yong Poovorawan
Journal:  PeerJ       Date:  2021-02-26       Impact factor: 2.984

4.  Impact of Vaccination on Rotavirus Genotype Diversity: A Nearly Two-Decade-Long Epidemiological Study before and after Rotavirus Vaccine Introduction in Sicily, Italy.

Authors:  Floriana Bonura; Leonardo Mangiaracina; Chiara Filizzolo; Celestino Bonura; Vito Martella; Max Ciarlet; Giovanni M Giammanco; Simona De Grazia
Journal:  Pathogens       Date:  2022-03-31

5.  Evolutionary changes between pre- and post-vaccine South African group A G2P[4] rotavirus strains, 2003-2017.

Authors:  Peter N Mwangi; Nicola A Page; Mapaseka L Seheri; M Jeffrey Mphahlele; Sandrama Nadan; Mathew D Esona; Benjamin Kumwenda; Arox W Kamng'ona; Celeste M Donato; Duncan A Steele; Valantine N Ndze; Francis E Dennis; Khuzwayo C Jere; Martin M Nyaga
Journal:  Microb Genom       Date:  2022-04

6.  Human rotavirus VP4 and VP7 genetic diversity and detection of GII norovirus in Ibadan as Nigeria introduces rotavirus vaccine.

Authors:  Meshach Maunta Maina; Adedayo Omotayo Faneye; Babatunde Olanrewaju Motayo; Ntung Nseabasi-Maina; Adekunle Johnson Adeniji
Journal:  J Int Med Res       Date:  2022-09       Impact factor: 1.573

Review 7.  Prevalence, Pattern and Genetic Diversity of Rotaviruses among Children under 5 Years of Age with Acute Gastroenteritis in South Africa: A Systematic Review and Meta-Analysis.

Authors:  Cornelius A Omatola; Ropo E Ogunsakin; Ademola O Olaniran
Journal:  Viruses       Date:  2021-09-23       Impact factor: 5.048

8.  High Prevalence of Coinfecting Enteropathogens in Suspected Rotavirus Vaccine Breakthrough Cases.

Authors:  Ceren Simsek; Mandy Bloemen; Daan Jansen; Leen Beller; Patrick Descheemaeker; Marijke Reynders; Marc Van Ranst; Jelle Matthijnssens
Journal:  J Clin Microbiol       Date:  2021-09-29       Impact factor: 5.948

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.